Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis-Reference-Cited by-同舟云学术

Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis

Published:2013-05-15 Issue:10 Volume:54 Page:2269-2273
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Skov Vibe,Riley Caroline Hasselbalch,Thomassen Mads,Larsen Thomas Stauffer,Jensen Morten K.,Bjerrum Ole Weis,Kruse Torben A.,Hasselbalch Hans Carl

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2013.764417

Reference47 articles.

1. The Myeloproliferative Disorders

2. Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis

3. Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis

4. Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance

5. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenetic Factors in the Pathogenesis of Myeloproliferative Neoplasms;Interdisciplinary Cancer Research;2024

2. Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape;International Journal of Molecular Sciences;2023-12-12

3. Targeting the chromatin structural changes of antitumor immunity;Journal of Pharmaceutical Analysis;2023-11

4. Role of Next Generation Immune Checkpoint Inhibitor (ICI) Therapy in Philadelphia Negative Classic Myeloproliferative Neoplasm (MPN): Review of the Literature;International Journal of Molecular Sciences;2023-08-07

5. Exploration of the role of NKG2D ligands MICA and MICB in JAK2 V617F‐positive myeloproliferative neoplasms;HLA;2023-04